← Back to VIR

VIR BIOTECHNOLOGY INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 06/08/2025Mar 2024Filed 08/05/2025
$239−$0$0.2$1.2$3$2.4$3.1$56
$80−$126−$163−$111−$121−$214−$138−$65
$0.47−$0.85−$1.17−$0.80−$0.88−$1.56−$1.02−$0.48
169147139138137137136135

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.